| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/25/2006 | EP1618218A2 Methods for prognosis and treatment of solid tumors |
| 01/25/2006 | EP1618184A2 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
| 01/25/2006 | EP1618181A2 Polyvalent protein complex |
| 01/25/2006 | EP1618134A2 Tissue factor antibodies and uses thereof |
| 01/25/2006 | EP1618132A2 Composition and methods for the treatment of immune disorders |
| 01/25/2006 | EP1618130A2 Therapeutic cancer vaccine |
| 01/25/2006 | EP1618127A2 The severe acute respiratory syndrome coronavirus |
| 01/25/2006 | EP1618126A2 Sars-related proteins |
| 01/25/2006 | EP1617870A2 Single chain antigen-binding polypeptides for polymer conjugation |
| 01/25/2006 | EP1617864A2 Epha2 and non-neoplastic hyperproliferative cell disorders |
| 01/25/2006 | EP1617805A2 Methods of preventing or treating respiratory conditions |
| 01/25/2006 | EP1547611A4 Medicinal agent and method for curing prostate diseases |
| 01/25/2006 | EP1495324A4 Use of monoclonal antibodies to distinguish protein conformational isoforms |
| 01/25/2006 | EP1461071A4 Muscle transcription factors |
| 01/25/2006 | EP1144650B1 Goodpasture antigen binding protein |
| 01/25/2006 | EP0980427B1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 01/25/2006 | EP0759781B1 Compositions for treating and preventing atherosclerosis |
| 01/25/2006 | CN1726394A Sets of digital antibodies directed against short epitopes, and methods using same |
| 01/25/2006 | CN1726227A Humanized antibody (H14.18) of the mouse 14.18 antibody binding to GD2 and its fusion with 1L-2 |
| 01/25/2006 | CN1726226A Antibodies that bind cell-associated CA125/0722P and methods of use thereof |
| 01/25/2006 | CN1726047A Vaccine comprising an antigen conjugated to low valency anti-CD40 or anti-CD28 antibodies |
| 01/25/2006 | CN1724666A Immune tbid gene and its coded protein and application |
| 01/25/2006 | CN1724665A Human new gene TRIKS and its coded protein |
| 01/25/2006 | CN1724664A Human HOLF 402 protein and its coding sequence |
| 01/25/2006 | CN1724569A Preparation method of vitelline antibody for resisting pstudorabies |
| 01/25/2006 | CN1723878A Use of polyphenol and its oxides |
| 01/25/2006 | CN1238508C Distillersyeast recombined hepatitis B virus surface antigen stream addition femrentation process |
| 01/25/2006 | CN1238499C Antibody against AIDS virus O and its production cell series and uses |
| 01/25/2006 | CN1238382C Molt-inhibiting hormone-1 protein of mitten crab |
| 01/25/2006 | CN1238381C Anti-cancer surface antigen of p185 mono-antigen mosaic antibody and its preparation |
| 01/25/2006 | CN1238379C New osteoclast formation inhibiting factor and its coding sequence and use |
| 01/25/2006 | CN1238375C Chlorine-ion/ bicarbonate radical exchange protein drived by sodium-ion |
| 01/25/2006 | CN1238367C Isolated nucleic acid molecules which encode T cell inducible factors (TIF), proteins encoded, and uses thereof |
| 01/24/2006 | US6989365 Methods of treatment with erythropoietin and albumin fusion protein |
| 01/24/2006 | US6989267 Methods of making microarrays with substrate surfaces having covalently bound polyelectrolyte films |
| 01/24/2006 | US6989262 Plasmin variants and uses thereof |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989255 for protection against staphylococcus infection; fusion proteins |
| 01/24/2006 | US6989250 Isolation of nucleotide sequences coding preferential protein; obtain nucleotide sequences, mutate, incubate with oligonucleotide primers, amplify and isolate single-stranded nucleotide sequences, generate preferential nucleic acids |
| 01/24/2006 | US6989248 Preventing or treating preferential skin disorders; obtain test animal, administer antiproliferative agent, monitor stem cell propagation, evaluate skin disorders |
| 01/24/2006 | US6989241 Assay for rapid detection of human activated protein C and highly specific monoclonal antibody therefor |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/24/2006 | US6989145 Chimeric antibody for use in the diagnosis and treatment of blood cancer and immune defects |
| 01/24/2006 | US6989144 Glycoprotein VI antibodies and uses thereof |
| 01/24/2006 | CA2351315C Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 01/23/2006 | WO2007015691A2 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 01/23/2006 | CA2576464A1 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 01/23/2006 | CA2513024A1 Vibrio cholerae lps detoxified derivatives and immunogenic compositions containing them |
| 01/23/2006 | CA2475736A1 Vibrio cholerae lps detoxified derivatives and immunogenic compositions containing them |
| 01/19/2006 | WO2006007471A1 Monoclonal antibodies to hiv-1 vpr and methods of using same |
| 01/19/2006 | WO2006007202A2 Canine cd20 compositions |
| 01/19/2006 | WO2006006710A1 Polypeptide having δ5 fatty acid unsaturating activity, polynucleotide coding for the polypeptide, and use thereof |
| 01/19/2006 | WO2006006695A1 Mouse monoclonal antibody recognizing acetyllysine, labeled antibody and utilization of the same |
| 01/19/2006 | WO2006006693A1 Anti-glypican 3 antibody |
| 01/19/2006 | WO2006006074A2 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 01/19/2006 | WO2006005961A1 Methods for the reversible protection of proteins during pathogen inactivation |
| 01/19/2006 | WO2006005940A2 Monoclonal anti-glut2 antibody |
| 01/19/2006 | WO2006005586A2 New polypeptide species specific to cerebrospinal fluid |
| 01/19/2006 | WO2006005585A2 Secreted polypeptide species differentially expressed during pregnancy |
| 01/19/2006 | WO2006005465A1 Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |
| 01/19/2006 | WO2005089285A3 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing |
| 01/19/2006 | WO2005073732A3 Lc/ms method of analyzing high molecular weight proteins |
| 01/19/2006 | WO2005038005A3 Shc proteins as therapeutic targets in proliferative diseases |
| 01/19/2006 | WO2005017149A8 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 01/19/2006 | WO2004094620A3 Truncated baff receptors |
| 01/19/2006 | US20060015958 Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission |
| 01/19/2006 | US20060015952 Screening assays and methods of tumor treatment |
| 01/19/2006 | US20060015949 Transgenic non-human animals for producing heterologous and chimeric antibodies |
| 01/19/2006 | US20060014937 Humanized antibody against S-surface antigen of hepatitis B virus |
| 01/19/2006 | US20060014936 Hybrid bacillus thuringiensis Cry1A/Cry1F DNA and plants and host cells transformed with same |
| 01/19/2006 | US20060014935 Fas ligand derived polypeptides |
| 01/19/2006 | US20060014932 Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same |
| 01/19/2006 | US20060014930 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 01/19/2006 | US20060014926 Human papillomavirus E6 and E7 polypeptides, mutant polypeptide retains 30% of the immunogenicity of an isolated polypeptide comprising human wild-type papillomavirus E6 and E7 |
| 01/19/2006 | US20060014681 Three-dimensional structure of complement receptor type 2 and uses thereof |
| 01/19/2006 | US20060014672 Tumor specific oligosaccharide epitopes and use thereof |
| 01/19/2006 | US20060014668 Antigenic gp 100 compounds for therapy and diagnosis and methods of using same |
| 01/19/2006 | US20060014252 Flk-1 binding protein |
| 01/19/2006 | US20060014243 Human G-protein chemokine receptor HSATU68 |
| 01/19/2006 | US20060014226 Nucleic acid and amino acid sequences of hemoglobin-response genes in Candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated Candida albicans infection |
| 01/19/2006 | US20060014225 Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 01/19/2006 | US20060014222 Antibodies |
| 01/19/2006 | US20060014204 Methods of inducing formation of functional and organized lymphatic vessels |
| 01/19/2006 | US20060014180 Human phosphatase RET31, and variants thereof |
| 01/19/2006 | US20060014166 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis |
| 01/19/2006 | US20060014160 Determining whether or not mammary gland sodium/iodide symporter (mgNIS) is expressed in breast tissue of the subject, whereinexpression of mgNIS in the breast tissue is detected using an antibody, specific for mgNIS, expression of mgNIS in the breast tissue of is indicative of breast cancer presence |
| 01/19/2006 | US20060013855 Bioactive stents for type II diabetics and methods for use thereof |
| 01/19/2006 | US20060013832 Methods for treating HIV infected subjects |
| 01/19/2006 | US20060013824 RSV proteins, antibodies, compositions, methods and uses |
| 01/19/2006 | US20060013822 Utilization of mhc class II binding motifs in immunization to produce immune, serum, monoclonal antibodies and vaccines |
| 01/19/2006 | US20060013818 Method of treating granuloma annulare or sarcoid |
| 01/19/2006 | US20060013817 identification of genetic products that are expressed in association with a tumor and the nucleic acid coding therefor. The invention relates to the therapy and diagnosis of diseases in which said genetic products that are expressed in association with a tumor are expressed in an aberrant manner. |
| 01/19/2006 | US20060013816 IgG4 constant region; Fab' fragment; antibody or antigen binding fragment inhibits binding of A2 or cA2 to human TNF- alpha , and binds to a neutralizing epitope of human TNF- alpha |
| 01/19/2006 | US20060013815 Human Mob-5 (IL-24) receptors and uses thereof |
| 01/19/2006 | US20060013813 Proteins and nucleic acids encoding same |
| 01/19/2006 | US20060013811 Methods of treating IgE-associated disorders and compositions for use therein |
| 01/19/2006 | US20060013810 Cancer, autoimmune and inflammatory disease, vaccines; binds to the extracellular domain of native human Fc gamma RIIB with greater affinity than to the extracellular domain of native human Fc gamma RIIA |
| 01/19/2006 | US20060013809 Immunotoxin derived from a recombinant human autoantibody and method of using thereof |
| 01/19/2006 | US20060013808 Treatment for asthma |
| 01/19/2006 | US20060013802 Pumping device equipped with catheter; directly delivering interleukin 10 signal transduction modifying agent to cerebrospinal fluid and/or brain tissue |